http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7211201-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9019c0ce5cb7b82c85e121f6cac86dce
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-1412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-133519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2019-0444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-133514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-13394
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-0266
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-2014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-2007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-2021
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1339
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-52
filingDate 2003-05-23^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-05-01^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d17f37c5e7810dea912fa5ccba155b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d09af768407ae3ba2fcffc2de78454a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d5a8eaa4bf270db10fef09af776531d
publicationDate 2007-05-01^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7211201-B2
titleOfInvention Antiferroelectric liquid crystal and its manufacturing method
abstract Rod-like molecules ( 1 ) are admixed into a smectic C liquid crystal ( 2 ). According to the least-energy principle for electrostatic energy each rod-like molecule ( 1 ) has its permanent dipole moment aligned in a direction along a boundary layer between adjacent molecular layers of the liquid crystal and such permanent dipoles in adjacent boundary layers are aligned with their dipole moments opposed to each other in the direction of orientation. The character “<” bar regions of rod-like molecules ( 1 ) cause liquid crystal molecules inclined along their major axes to be axially inclined in an opposite direction every other layer whereby a smectic C A phase is formed in which the layer of liquid crystal molecules inclined in one direction and the layer of those inclined in the other direction alternate. Using a chiral smectic C A liquid crystal formed from chiral smectic C-phase liquid crystal molecules by substituting a terminal group of each such molecule with an optically active group gives rise to an antiferroelectric liquid crystal.
priorityDate 2002-05-29^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08217728-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1215195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0882778-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6924009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5316694-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08333575-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246815283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231200005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69415324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231201663
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69415323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243706369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128139639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231201659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246599889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428146747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231193465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18457949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12195255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154106004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231200000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231199860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244759073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127973412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15809833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428146799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231193458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129597032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69417972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231193453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154047161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23071250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231193462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23071249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226817950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129180134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423083033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23071251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69417429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431627218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424617036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431955016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69415321

Showing number of triples: 1 to 80 of 80.